Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;34(4):735-747.
doi: 10.1016/j.bpa.2020.04.012. Epub 2020 Apr 23.

The optimum management of nausea and vomiting during and after cesarean delivery

Affiliations
Review

The optimum management of nausea and vomiting during and after cesarean delivery

Hon Sen Tan et al. Best Pract Res Clin Anaesthesiol. 2020 Dec.

Abstract

Intraoperative and postoperative nausea and vomiting (IONV and PONV) afflict up to 80% of parturients undergoing cesarean delivery with neuraxial anesthesia. Preventing nausea and emesis is a top priority for women undergoing cesarean delivery and is included in the quality of recovery measures and enhanced recovery after cesarean delivery protocols. The majority of known perioperative emetic triggers can be avoided or mitigated by optimizing anesthetic and surgical management. IONV may arise from spinal anesthesia-induced hypotension, intraoperative pain, and medications such as uterotonics and antibiotics. Furthermore, uterine exteriorization and peritoneal irrigation increase IONV risk. Conversely, preventing PONV mainly focuses on optimizing analgesia through an opioid-sparing, multimodal strategy. In addition, combination prophylactic antiemetic therapy should be instituted in this high-risk population to further reduce the risk of IONV and PONV.

Keywords: cesarean delivery; intrathecal opioids; nausea; neuraxial anesthesia; vomiting.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Dr. Habib has previously received research support and honoraria from Acacia Pharma, and research support from Pacira Biosciences.

MeSH terms